SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395070-08-000002
Filing Date
2008-06-30
Accepted
2008-06-30 17:18:45
Documents
1
Period of Report
2008-06-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3894
  Complete submission text file 0001395070-08-000002.txt   6008
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 281-272-9331
Rill Donna R (Reporting) CIK: 0001395070 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 08926819